Literature DB >> 33939124

Cytokine response following perturbation of the cervicovaginal milieu during HPV genital infection.

Christian Selinger1,2, Massilva Rahmoun3, Carmen Lia Murall3, Claire Bernat3, Vanina Boué3, Marine Bonneau4, Christelle Graf4, Sophie Grasset3, Soraya Groc3, Jacques Reynes5, Christophe Hirtz6, Nathalie Jacobs7, Samuel Alizon3.   

Abstract

Human papillomaviruses (HPVs) are oncogenic viruses causing most cervical cancers. Highly prevalent in young, sexually active women, only a minority of HPV infections persist. To better characterize the immuno-modulatory impact of early HPV infections, we measured changes in a panel of 20 cytokines in cervicovaginal samples collected from young women who were tested for HPV and self-reported for genital inflammation and infection symptoms. Multi-factor statistical analyses revealed that increased IL-1Alpha and IL-12/IL-23p40 concentrations were associated with HPV infection and that macrophage inflammatory proteins were associated in particular with high-risk HPV infections. ClinicalTrials.gov identifier NCT02946346.

Entities:  

Keywords:  Cytokines; Human papillomavirus; Mucosal immunity; Natural history

Mesh:

Substances:

Year:  2021        PMID: 33939124     DOI: 10.1007/s12026-021-09196-2

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  28 in total

1.  HPV cervical infections and serological status in vaccinated and unvaccinated women.

Authors:  Carmen Lía Murall; Bastien Reyné; Christian Selinger; Claire Bernat; Vanina Boué; Sophie Grasset; Soraya Groc; Massilva Rahmoun; Noemi Bender; Marine Bonneau; Vincent Foulongne; Christelle Graf; Eric Picot; Marie-Christine Picot; Vincent Tribout; Tim Waterboer; Ignacio G Bravo; Jacques Reynes; Michel Segondy; Nathalie Boulle; Samuel Alizon
Journal:  Vaccine       Date:  2020-11-07       Impact factor: 3.641

Review 2.  MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells.

Authors:  Patrizia Leone; Eui-Cheol Shin; Federico Perosa; Angelo Vacca; Franco Dammacco; Vito Racanelli
Journal:  J Natl Cancer Inst       Date:  2013-07-12       Impact factor: 13.506

3.  The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women.

Authors:  A B Moscicki; S Shiboski; J Broering; K Powell; L Clayton; N Jay; T M Darragh; R Brescia; S Kanowitz; S B Miller; J Stone; E Hanson; J Palefsky
Journal:  J Pediatr       Date:  1998-02       Impact factor: 4.406

Review 4.  Immune evasion mechanisms of human papillomavirus: An update.

Authors:  Alina Steinbach; Angelika B Riemer
Journal:  Int J Cancer       Date:  2017-09-13       Impact factor: 7.396

Review 5.  Human papillomavirus and cervical cancer.

Authors:  Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana C Rodriguez; Sholom Wacholder
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

6.  Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.

Authors:  Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Philip E Castle; Diane Solomon; Robert Burk
Journal:  J Natl Cancer Inst       Date:  2008-03-25       Impact factor: 13.506

7.  Worldwide burden of cancer attributable to HPV by site, country and HPV type.

Authors:  Catherine de Martel; Martyn Plummer; Jerome Vignat; Silvia Franceschi
Journal:  Int J Cancer       Date:  2017-06-08       Impact factor: 7.396

8.  Natural history, dynamics, and ecology of human papillomaviruses in genital infections of young women: protocol of the PAPCLEAR cohort study.

Authors:  Carmen Lía Murall; Massilva Rahmoun; Christian Selinger; Monique Baldellou; Claire Bernat; Marine Bonneau; Vanina Boué; Mathilde Buisson; Guillaume Christophe; Giuseppe D'Auria; Florence De Taroni; Vincent Foulongne; Rémy Froissart; Christelle Graf; Sophie Grasset; Soraya Groc; Christophe Hirtz; Audrey Jaussent; Julie Lajoie; Frédérique Lorcy; Eric Picot; Marie-Christine Picot; Jacques Ravel; Jacques Reynes; Thérèse Rousset; Aziza Seddiki; Martine Teirlinck; Vincent Tribout; Édouard Tuaillon; Tim Waterboer; Nathalie Jacobs; Ignacio G Bravo; Michel Segondy; Nathalie Boulle; Samuel Alizon
Journal:  BMJ Open       Date:  2019-06-11       Impact factor: 2.692

Review 9.  Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response.

Authors:  Alfredo Amador-Molina; José Fernando Hernández-Valencia; Edmundo Lamoyi; Adriana Contreras-Paredes; Marcela Lizano
Journal:  Viruses       Date:  2013-10-28       Impact factor: 5.048

10.  Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation.

Authors:  Nunzia Zanotta; Maria Lina Tornesello; Clorinda Annunziata; Giovanni Stellato; Franco Maria Buonaguro; Manola Comar
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

View more
  1 in total

1.  Concomitant and productive genital infections by HSV-2 and HPV in two young women: A case report.

Authors:  Ilkay Başak Uysal; Vanina Boué; Carmen Lia Murall; Christelle Graf; Christian Selinger; Christophe Hirtz; Claire Bernat; Jacques Ravel; Jacques Reynes; Marine Bonneau; Massilva Rahmoun; Michel Segondy; Nathalie Boulle; Sophie Grasset; Soraya Groc; Tim Waterboer; Vincent Tribout; Ignacio G Bravo; Sonia Burrel; Vincent Foulongne; Samuel Alizon; Nicolas Tessandier
Journal:  IDCases       Date:  2022-08-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.